Skip to content
← The Index board

Promising · 5.8/10

Celebrex (Celecoxib)

Evidence A · strong evidence ▲ 28.5% momentum 🥇 First scout open
5.8/ 10

Celecoxib is a prescription COX-2 selective NSAID for arthritis and acute pain. Nissen 2016 PRECISION found cardiovascular noninferiority versus ibuprofen and naproxen at moderate doses, while Derry 2013 found single-dose 400 mg celecoxib effective for acute postoperative pain. Read the full breakdown →

The prediction game

Where does Celebrex (Celecoxib) go in 12 months?

Lock a call and say how sure you are. Right and confident earns the most; a leaderboard spot is the prize. No money, no stakes.

The Crowd’s Call

Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.

Your 12-month call on Celebrex (Celecoxib)

New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.

Be the first scout on record for Celebrex (Celecoxib). Permanent credit on this page, plus points when your call resolves.

One call per intervention. It locks the moment you submit (no edits, no cancels) and resolves in 12 months. See the scout leaderboard →

Weigh In

Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.

Tried it in real life?

Which ring does it deserve?

Same as above — one verification covers all your entries here.

Ring Promising Momentum 28.5% Updated Jul 20, 2026 How the Index ranks →

Verdict by Nick Urban, host of the High Performance Longevity podcast.

For education only, not medical advice. Supplements, peptides, and protocols can interact with medications and conditions. Talk to a qualified clinician before starting anything here.